ASX:LCT Living Cell Technologies (LCT) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock Analysis About Living Cell Technologies Stock (ASX:LCT) 30 days 90 days 365 days Advanced Chart Get LCT alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume76,622 shsAverage VolumeN/AMarket Capitalization$24.53 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewLiving Cell Technologies Limited, a biotechnology company, discovers, develops, and commercializes regenerative treatments that use naturally occurring cells to restore functions in Australia and New Zealand. It is developing NTCELL, an alginate-coated capsule, which is in phase IIb clinical trial for the treatment of Parkinson's disease. The company was founded in 1987 and is based in Melbourne, Australia.Read More… Receive LCT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Living Cell Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address LCT Stock News HeadlinesMysterious stem cells: LCT procedure (3)December 29, 2024 | msn.comMolecular 'ZIP code' draws killer T cells to brain tumorsDecember 8, 2024 | msn.comThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…February 23, 2025 | Crypto 101 Media (Ad)New 3D Bio-printer Injects Living Cells Directly Onto Injuries To Heal Bones and CartilageDecember 8, 2024 | msn.comResearchers use single-cell technologies and microfluidics to print organ structuresNovember 4, 2024 | msn.comBiochemists create protocells to explore how lipids may have led to first cell membranesNovember 3, 2024 | msn.comCompact in-incubator imaging device allows real-time remote monitoring of cell growthOctober 30, 2024 | msn.comLiving Cell Technologies Announces Director’s Interest ChangeOctober 28, 2024 | markets.businessinsider.comSee More Headlines LCT Stock Analysis - Frequently Asked Questions How were Living Cell Technologies' earnings last quarter? Living Cell Technologies Limited (ASX:LCT) released its quarterly earnings results on Tuesday, February, 19th. The company reported $0.00 earnings per share for the quarter. What other stocks do shareholders of Living Cell Technologies own? Based on aggregate information from My MarketBeat watchlists, some other companies that Living Cell Technologies investors own include eWellness Healthcare (EWLL), Energous (WATT), Cheniere Energy (LNG) and AllianceBernstein Global High Income Fund (AWF). Company Calendar Last Earnings2/19/2019Today2/23/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolASX:LCT CUSIPN/A CIKN/A Webwww.lctglobal.com Phone61 3 8689 9997FaxN/AEmployees147,000Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-2,110,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-54.06% Return on Assets-18.67% Debt Debt-to-Equity RatioN/A Current Ratio9.35 Quick Ratio17.84 Sales & Book Value Annual Sales$3,405.00 Price / Sales0.00 Cash FlowN/A Price / Cash Flow2.17 Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares1,640,000,000Free FloatN/AMarket Cap$24.53 million OptionableNot Optionable Beta0.48 (Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free Report This page (ASX:LCT) was last updated on 2/23/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredNvidia > DeepSeekEveryone's getting it all wrong … Sure, DeepSeek's reveal caused AI stocks to tumble … But, in the long ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Living Cell Technologies Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Living Cell Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
